PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)

被引：0

作者：

Ansen, S. ^{[1
]}

Schultheis, A. ^{[2
]}

Hellmich, M. ^{[3
]}

Leenders, F. ^{[4
]}

Zander, T. ^{[1
]}

Michels, S. ^{[1
]}

Brockmann, M. ^{[5
]}

Stoelben, E. ^{[6
]}

Groen, H. ^{[7
,8
]}

Timens, W. ^{[7
,9
]}

Buettner, R. ^{[2
]}

Thomas, R. K. ^{[4
]}

Perner, S. ^{[10
]}

Wolf, J. ^{[1
]}

机构：

[1] Univ Hosp Cologne, Dept Internal Med 1, Ctr Integrated Oncol Koln Bonn, Cologne, Germany

[2] Univ Hosp Cologne, Ctr Integrated Oncol, Inst Pathol, Cologne, Germany

[3] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany

[4] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Dept Translat Genom, D-50931 Cologne, Germany

[5] Hosp Merheim, Dept Pathol, Cologne, Germany

[6] Kliniken Stadt Koln gGmbH, Lungenklin Merheim, Cologne, Germany

[7] Univ Groningen, Groningen, Netherlands

[8] Univ Med Ctr Groningen, Dept Pulm Dis, NL-9713 AV Groningen, Netherlands

[9] Univ Med Ctr Groningen, Dept Pathol, NL-9713 AV Groningen, Netherlands

[10] Univ Hosp Bonn, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V30

引用

页码：5 / 6

页数：2

共 50 条

[21] Efficacy and safety of the PD-1/PD-L1 in metastasic non-small cell lung cancer (NSCLC)
Gonzalez-Velez, Abel
Pino-Villareal, Luis E.
Barrera-Barinas, Alexander
Castillo-Niuman, Andrea
Tolosa-Perez, Erica N.
Castelblanco, Diana, I
Pinzon-Florez, Carlos E.
Yomayusa, Nancy
GACETA MEXICANA DE ONCOLOGIA, 2021, 20 (03): : 111 - 123
[22] PD-L1 Expression, EGFR Mutations and ALK Expression in Non-Small Cell Lung Cancer (NSCLC) Patients from Brazil
Alves Da Silva, A. V.
Tavora, F.
Martins Neto, F.
Oliveira, A. C. D. S.
Alves, M.
Carneiro, B.
Lima, A. M.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1020 - S1020
[23] PD-L1 expression by RNA-sequencing and survival from pembrolizumab in non-small cell lung cancer (NSCLC)
Nesline, Mary K.
Pabla, Sarabjot
Lee, Yong Hee
DePietro, Paul
Early, Amy
Klein, Roger
Zhang, Shengle
Conroy, Jeffrey
CANCER RESEARCH, 2022, 82 (12)
[24] Screening for PD-L1 expression by immunohistochemistry in non-small cell lung cancer (NSCLC) in the era of immunotherapy: a national study
Breen, K.
McCormack, J.
Fabre, A.
IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S417 - S418
[25] PD-L1 expression in paired non-small cell lung cancer tumor samples
Kim, Jhingook
Sorensen, Steffen Filskov
Choi, Yoon-La
Wang, Zhen
Sun, Jong-Mu
Choi, Hyejoo
Georgsen, Jeanette Baehr
Dolled-Filhart, Marisa
Emancipator, Kenneth
Wu, Dianna Y.
Meldgaard, Peter
Zhou, Wei
Hager, Henrik
CANCER RESEARCH, 2015, 75
[26] Mutational landscapes and PD-L1 expression in non-small cell lung cancer.
Zhang, Kang
Wang, Guanghui
Guo, Chao
Chen, Xinyu
Zhang, Shiyue
Wang, Wenjing
Yao, Ming
Liu, Angen
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[27] Concomitant PD-L1 Expression and Driver Oncogenes in Non-small Cell Lung Cancer
McNeill, N.
Horton, J. J.
Freitas, T. A.
Shiller, M.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06) : 1003 - 1003
[28] PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations
Scheel, Andreas H.
Ansen, Sascha
Schultheis, Anne M.
Scheffler, Matthias
Fischer, Rieke N.
Michels, Sebastian
Hellmich, Martin
George, Julie
Zander, Thomas
Brockmann, Michael
Stoelben, Erich
Groen, Harry
Timens, Wim
Perner, Sven
von Bergwelt-Baildon, Michael
Buettner, Reinhard
Wolf, Juergen
ONCOIMMUNOLOGY, 2016, 5 (05):
[29] Liquid Biopsy Based Monitoring of PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients for Immunotherapy
Singh, G.
Leong, M.
Sylvester, S.
Lee, Y.
Johnson, C.
Wu, A.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06) : 1006 - 1006
[30] Screening for PD-L1 expression by immunohistochemistry in non-small cell lung cancer (NSCLC) in the era of immunotherapy: a national study
Breen, K.
McCormack, J.
Fabre, A.
IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S417 - S418

← 1 2 3 4 5 →